Results 1 to 10 of about 199,842 (184)

Novel lipid antigens for NKT cells in cancer [PDF]

open access: yesFrontiers in Immunology, 2023
Cancer immunotherapy aims to unleash the power of the immune system against tumors without the side effects of traditional chemotherapy. Immunotherapeutic methods vary widely, but all follow the same basic principle: overcome the barriers utilized by ...
Michael S. Lee   +3 more
doaj   +4 more sources

Lipid antigens in immunity. [PDF]

open access: yesBiol Chem, 2014
Abstract Lipids are not only a central part of human metabolism but also play diverse and critical roles in the immune system. As such, they can act as ligands of lipid-activated nuclear receptors, control inflammatory signaling through bioactive lipids such as prostaglandins, leukotrienes, lipoxins, resolvins, and protectins, and ...
Dowds CM   +3 more
europepmc   +4 more sources

Lipid Antigens: Revealing the Hidden Players in Adaptive Immune Responses [PDF]

open access: yesBiomolecules
Traditionally, research on the adaptive immune system has focused on protein antigens, but emerging evidence has underscored the essential role of lipid antigens in immune modulation.
Tamana Eskandari   +5 more
doaj   +2 more sources

Structural determination of lipid antigens captured at the CD1d-T-cell receptor interface. [PDF]

open access: yesProc Natl Acad Sci U S A, 2017
Glycolipid antigens recognized by αβ T-cell receptors (TCRs) drive the activation of invariant natural killer T (iNKT) cells, a specialized subset of innate T lymphocytes.
Brennan PJ   +10 more
europepmc   +4 more sources

How T cells grasp mycobacterial lipid antigens. [PDF]

open access: yesProc Natl Acad Sci U S A, 2017
Solving the mechanism by which MHC I and II proteins capture protein fragments represented a triumph for T cell biologists. This discovery highlighted the peptidic nature of antigens for T cells. Investigation of MHC-peptide–T cell receptor (TCR) interactions provides the basis for epitope mapping, which is the process of identifying the particular ...
Moody DB.
europepmc   +4 more sources

The T cell response to lipid antigens of Mycobacterium tuberculosis [PDF]

open access: yesFrontiers in Immunology, 2014
T cells recognize lipid antigens presented by dedicated antigen presenting molecules that belong to the CD1 family. This review discusses the structural properties of CD1 molecules, the nature of mycobacterial lipid antigens, and the phenotypic and ...
Gennaro eDe Libero   +2 more
doaj   +2 more sources

Buffy Coat Processing Impacts on Monocytes’ Capacity to Present Lipid Antigens [PDF]

open access: yesBiomedicines, 2023
Buffy Coats, generated from a blood donor’s whole blood bag unit, are commonly used in biomedical research as a source of leukocytes due to the high number of cells that can be recovered from each Buffy Coat.
Inês Mondragão-Rodrigues   +1 more
doaj   +2 more sources

New synthetic lipid antigens for rapid serological diagnosis of tuberculosis. [PDF]

open access: yesPLoS ONE, 2017
BackgroundDuring pulmonary tuberculosis (PTB) antibodies are generated to trehalose esters of mycolic acids which are cell wall lipids of Mycobacterium tuberculosis (Mtb). Attempts have been made to use these complex natural mixtures in serological tests
Alison Jones   +7 more
doaj   +2 more sources

Preparing Adjuvanted Nanoliposomes for Applications Toward Recombinant Influenza Vaccine Development [PDF]

open access: yesBio-Protocol
Nanoparticle vaccines can provide advantages over traditional vaccine methodologies, including adjuvant delivery to enhance the effectiveness of recombinant antigens.
Zachary Sia   +5 more
doaj   +2 more sources

Atypical natural killer T-cell receptor recognition of CD1d–lipid antigens [PDF]

open access: yesNature Communications, 2016
The invariant αβTCR of type I NKT cells recognizes a lipid α-GalCer presented by CD1d. Here the authors describe atypical α-GalCer-reactive NKT cells with diverse TCRs, which bind to CD1d-α-GalCer in a manner distinct from type I NKT cells, thus ...
Jérôme Le Nours   +13 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy